{"transactions":[{"id":1137323,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2025-05-22T17:59:29.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5636,"price":2.675,"value":15076.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the selling price of all sales by the Reporting Person on May 21, 2025. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at the certain price."}],"balance_after":247031,"source":{"system":"sec-edgar","filing":"0001628280-25-027201","document":"wk-form4_1747936763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828025027201/wk-form4_1747936763.xml","form_type":"4"}},{"id":1183684,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2025-04-02T21:17:05.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":162281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":252667,"source":{"system":"sec-edgar","filing":"0001799191-25-000019","document":"wk-form4_1743628617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919125000019/wk-form4_1743628617.xml","form_type":"4"}},{"id":1188870,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Warrant","published_at":"2025-03-28T21:33:04.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":4528,"price":0.125,"value":566.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act."}],"balance_after":4528,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":4528},"source":{"system":"sec-edgar","filing":"0001079973-25-000519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000519/ownership.xml","form_type":"4"}},{"id":1188869,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-28T21:33:04.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":9056,"price":1.0417,"value":9433.6352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."}],"balance_after":90386,"source":{"system":"sec-edgar","filing":"0001079973-25-000519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000519/ownership.xml","form_type":"4"}},{"id":1341673,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2024-12-05T21:02:18.000Z","date":"2024-12-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1130,"price":0.16,"value":180.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average selling price of all sales by the Reporting Person on December 3, 2024 within a one-dollar range. Actual prices ranged from $0.156 to $0.160. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":81330,"source":{"system":"sec-edgar","filing":"0001799191-24-000065","document":"wk-form4_1733432530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000065/wk-form4_1733432530.xml","form_type":"4"}},{"id":1503765,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-05-23T22:33:02.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":175299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":175299,"derivative":{"exercise_price":2,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":175299},"source":{"system":"sec-edgar","filing":"0001799191-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000008/edgardoc.xml","form_type":"4"}},{"id":1503764,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-05-23T22:33:02.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":70120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":82460,"source":{"system":"sec-edgar","filing":"0001799191-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000008/edgardoc.xml","form_type":"4"}},{"id":1723980,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-05T00:42:59.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":30849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":30849,"derivative":{"exercise_price":1.71,"expiration_date":"2033-11-30","underlying":"Common stock","underlying_shares":30849},"source":{"system":"sec-edgar","filing":"0001628280-23-040679","document":"wk-form4_1701736970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023040679/wk-form4_1701736970.xml","form_type":"4"}},{"id":1723979,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":79396,"kind":"person","name":"Castle Jeremy","position":1,"cik":"0001992507","reported_name":"Castle Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2023-12-05T00:42:59.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":12340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 30, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001628280-23-040679","document":"wk-form4_1701736970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023040679/wk-form4_1701736970.xml","form_type":"4"}}]}